Live Science on MSN4h
Why America is losing its 50-year 'war on cancer,' according to scientist Nafis HasanHowever, the nation has now been embroiled in this "war" for over 50 years, and we are nowhere closer to victory, argues ...
UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an early-phase oncolytic virus that could work like a turbocharged Bacillus Calmette ...
FRIDAY, Feb. 14, 2025 (HealthDay News) – Kidney transplants can be lifesaving, but a new study suggests that some recipients ...
Discover how HPV silently triggers throat cancer, why vaccination rates are dropping, and what medical experts say about ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...
Upon systemic infection from mosquito bites, Semliki Forest virus causes mild blood viremia ... AI Innovation Unlocks Non-Surgical Way to Detect Brain Cancer Spread Jan. 14, 2025 — Researchers ...
News Medical on MSN2d
Breakthrough discovery unveils potential treatment for hepatitis BIn their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...
This move is part of UroGen's strategy to develop locally administered therapies for bladder cancer and other specialty cancers. With a current market capitalization of $457 million and a healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback